Sandi A Kwee (Sandi Kwee)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Machine Learning

Top Venues

JCO clinical cancer informatics

Cancer research

Hepatoma research

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sandi A Kwee, Linda L Wong, Christina Ludema, Chris K Deng, Deborah Taira, Todd B Seto, Douglas Landsittel
Target Trial Emulation: A Design Tool for Cancer Clinical Trials. JCO clinical cancer informatics 7 (2023)
Sandi A Kwee, Linda L Wong, Christina Ludema, Chris K Deng, Deborah Taira, Todd B Seto, Douglas Landsittel
Target Trial Emulation: A Design Tool for Cancer Clinical Trials. JCO clinical cancer informatics 7 (2023)
Sandi A Kwee, Xin Chen
Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities. Hepatoma research 8 (2022)
Sandi A Kwee, Maarit I Tiirikainen, Miles M Sato, Jared D Acoba, Runmin Wei, Wei Jia, Loic Le Marchand, Linda Lou Wong
Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma. Cancer research 79 (7) (2019)
Erin B Evangelista, Sandi A Kwee, Miles M Sato, Lu Wang, Christoph Rettenmeier, Guoxiang Xie, Wei Jia, Linda L Wong
Phospholipids are A Potentially Important Source of Tissue Biomarkers for Hepatocellular Carcinoma: Results of a Pilot Study Involving Targeted Metabolomics. Diagnostics (Basel, Switzerland) 9 (4) (2019)
Sandi A Kwee, Linda Wong, Owen T M Chan, Sumodh Kalathil, Naoky Tsai
PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer. Radiology 287 (1) (2018)